A unified and concise first asymmetric total synthesis of (−)-citreoisocoumarin
(2), (−)-citreoisocoumarinol (3),
12-epi-citreoisocoumarinol (4), and
(−)-mucorisocoumarins A (5) and B (6) have been accomplished from the common intermediate (−)-6-O-methyl-citreoisocoumarin (1). Central to
the synthetic approach is a regioselective gold(I)-catalyzed 6-endo-dig cyclization strategy for the construction
of the isocoumarin skeleton. The other key steps in this approach
included Sonogashira coupling, Tsuji-Wacker oxidation, Evans-Saksena’s
1,3-anti-reduction, and Narasaka-Prasad’s
1,3-syn-reduction. The synthetic results unambiguously
confirmed the absolute configuration of the natural products mucorisocoumarins
A and B as (−)-(10R,12S)-5 and (+)-(10S,12S)-6, respectively.
The synthesis of 2,6-trans-disubstituted tetrahydropyrans following the Mukaiyama type aldol reaction through C–C bond formation demonstrates the practicality of this protocol in the total synthesis of diospongin A and B.
An efficient, cost effective and protecting group tolerant CuBr2-catalyzed synthesis of 2,6-trans-disubstituted tetrahydropyran with excellent diastereoselectivity, demonstrated in the total synthesis of decytospolides A and B and their C6-epimers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.